Retinopathia praematurorum (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Retinopathia praematurorum" in German language version.

refsWebsite

Global rank German rank

2^nd place

3^rd place

4^th place

7^th place

123^rd place

6^th place

5,401^st place

312^th place

68^th place

29^th place

2,650^th place

1,472^nd place

awmf.org

Tim U. Krohne, Alexandra T. Camp, Johanna M. Pfeil, Andreas Müller, Andreas Stahl, Wolf A. Lagrèze, Jeany Q. Li; EU-ROP Registry Study Group: Retinopathy of prematurity in Germany over 13 years: incidences, treatment preferences and effects of national guideline changes. In: Archives of Disease in Childhood - Fetal and Neonatal Edition. 2024, doi:10.1136/archdischild-2024-327133, PMID 38816192.
Andreas Stahl, Tim U. Krohne, Nicole Eter, Isabel Oberacher-Velten, Rainer Guthoff: Comparing Alternative Ranibizumab Dosages for Safety and Efficacy in Retinopathy of Prematurity: A Randomized Clinical Trial. In: JAMA Pediatrics. Band 172, Nr. 3, 1. März 2018, ISSN 2168-6203, S. 278–286, doi:10.1001/jamapediatrics.2017.4838 (jamanetwork.com [abgerufen am 28. September 2020]).
Andreas Stahl, Domenico Lepore, Alistair Fielder, Brian Fleck, James D. Reynolds: Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial. In: The Lancet. Band 394, Nr. 10208, 26. Oktober 2019, ISSN 0140-6736, S. 1551–1559, doi:10.1016/S0140-6736(19)31344-3, PMID 31522845.

Andreas Stahl, Tim U. Krohne, Nicole Eter, Isabel Oberacher-Velten, Rainer Guthoff: Comparing Alternative Ranibizumab Dosages for Safety and Efficacy in Retinopathy of Prematurity: A Randomized Clinical Trial. In: JAMA Pediatrics. Band 172, Nr. 3, 1. März 2018, ISSN 2168-6203, S. 278–286, doi:10.1001/jamapediatrics.2017.4838 (jamanetwork.com [abgerufen am 28. September 2020]).

Tim U. Krohne, Alexandra T. Camp, Johanna M. Pfeil, Andreas Müller, Andreas Stahl, Wolf A. Lagrèze, Jeany Q. Li; EU-ROP Registry Study Group: Retinopathy of prematurity in Germany over 13 years: incidences, treatment preferences and effects of national guideline changes. In: Archives of Disease in Childhood - Fetal and Neonatal Edition. 2024, doi:10.1136/archdischild-2024-327133, PMID 38816192.
Andreas Stahl, Domenico Lepore, Alistair Fielder, Brian Fleck, James D. Reynolds: Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial. In: The Lancet. Band 394, Nr. 10208, 26. Oktober 2019, ISSN 0140-6736, S. 1551–1559, doi:10.1016/S0140-6736(19)31344-3, PMID 31522845.

Andreas Stahl, Tim U. Krohne, Nicole Eter, Isabel Oberacher-Velten, Rainer Guthoff: Comparing Alternative Ranibizumab Dosages for Safety and Efficacy in Retinopathy of Prematurity: A Randomized Clinical Trial. In: JAMA Pediatrics. Band 172, Nr. 3, 1. März 2018, ISSN 2168-6203, S. 278–286, doi:10.1001/jamapediatrics.2017.4838 (jamanetwork.com [abgerufen am 28. September 2020]).
Andreas Stahl, Domenico Lepore, Alistair Fielder, Brian Fleck, James D. Reynolds: Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial. In: The Lancet. Band 394, Nr. 10208, 26. Oktober 2019, ISSN 0140-6736, S. 1551–1559, doi:10.1016/S0140-6736(19)31344-3, PMID 31522845.